Chitosan layered gold nanorods as synergistic therapeutics for photothermal ablation and gene silencing in triple-negative breast cancer. (1st October 2015)

• Record Type: Journal Article
• Authors: Yang, Zhizhou; Liu, Tengfei; Xie, Yan; Sun, Zhaorui; Liu, Hongmei; Lin, Jinfeng; Liu, Changjing; Mao, Zong-Wan; Nie, Shinan
• Is Part Of: Acta biomaterialia. Volume 25(2015)
• Page Start: 194
• Page End: 204
• Publication Date: 2015-10-01
• Subjects: Breast cancer -- Chitosan -- Gold nanorods -- Photothermal ablation -- Small interfering RNA; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2015.07.026
• Languages: English
• ISSNs: 1742-7061

Abstract

Graphical abstract: Treatment options for triple-negative breast cancer (TNBC) are limited, as patients do not respond to endocrine or targeted therapies, making this a difficult disease to treat. Multifunctional Chit-Au NRs were fabricated using a layer-by-layer assembly approach for delivery of siRNA gene silencing agents and thermal therapy to TNBC cells. This platform successfully suppressed oncogene expression in vitro and in vivo, resulting in anticancer activity, which was further enhanced through NIR irradiation. Abstract: Small interfering RNAs (siRNAs) are extensively studied due to their promising potential as therapeutic agents for a wide variety of diseases, including cancer. However, efficient delivery of siRNAs to target cells and tissues is problematic due to a lack of suitable delivery vehicles. In this work, we developed a layer-by-layer assembled chitosan-gold nanorods (Chit-Au NRs) siRNA delivery system to overcome biological barriers upon systemic injection. This platform was able to protect siRNAs form degradation upon exposure to ribonuclease (RNase) or serum. Confocal and intravital microscopy reveals that Chit-Au NRs/siRNAs are successfully delivered into target cells and tissue, and can efficiently escape from endosomal/lysosomal structures. Furthermore, Chit-Au NRs/siRNA were found to accumulate in high levels in tumor tissue. The delivery system was able to inhibit the oncogene expression (pyruvate kinase isozymeM2, PKM2) in MDA-MB-231 triple negative breast cancer cells, resulting in suppression of cell proliferation and migration. Moreover, the anticancer efficacy was further enhanced through NR-mediated photothermal ablation. In conclusion, the synergistic therapeutic properties of Chit-Au NRs/siRNA enable effective suppression of cancer growth. Statement of Significance: Small interfering RNA (siRNA) therapy has promising therapeutic applications, since the expression of any protein can be suppressed. However the successful implementation of siRNA has been challenging, due to rapid degradation, poor intracellular uptake and insufficient endosomal escape. Here, we have developed a gold nanorod/chitosan-based delivery vehicle for siRNA therapy. This platform successfully overcomes the afore-mentioned challenges and can simultaneously be used for photothermal therapy, due to the optical properties of gold nanorods. We show that the anticancer activity is dramatically improved by combining thermal therapy with gene silencing. Furthermore, the Au NRs carrier shows high accumulation in tumor tissue and high transfection efficiency. This manuscript has been reviewed and approved by all co-authors. The research has not been disclosed or published and is not under consideration for publication elsewhere. We would appreciate if the manuscript could be reviewed and considered for publication in Acta BIOMATERIALIA .